Neutrophils act as frontline immune response mediators and are critical in fighting infections in tissues such as the gut and lungs. Until now, the mechanisms that control the movement of neutrophils to specific sites of infection without damaging healthy tissues along the way were unknown.

The findings, published in the journal Science Advances, identify a potential new target for anti-inflammatory drugs to treat conditions including chronic inflammatory diseases of the gut and lung.